Can a woman in the third trimester of pregnancy safely take omeprazole 20 mg for gastro‑oesophageal reflux (heartburn)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, omeprazole 20 mg can be safely taken during the third trimester of pregnancy for heartburn.

Omeprazole is considered safe for use in the third trimester of pregnancy, though it should be reserved for moderate to severe heartburn that has not responded to first-line therapies. 1

Treatment Algorithm for Heartburn in Third Trimester

The approach to managing gastroesophageal reflux in pregnancy follows a stepwise escalation 2:

First-Line: Lifestyle and Dietary Modifications

  • Reduce spicy, fatty, acidic, and fried foods
  • Eat small, frequent, bland meals (BRAT diet: bananas, rice, applesauce, toast)
  • Identify and avoid specific triggers
  • Elevate head of bed for nighttime symptoms 2

Second-Line: Non-Systemic Agents

If lifestyle changes fail, start with:

  • Calcium-containing antacids or alginates (Grade A recommendation) 3
  • Sucralfate if symptoms persist (Grade C recommendation) 3

Third-Line: H2-Receptor Antagonists

Before moving to PPIs, try H2-receptor antagonists (avoid nizatidine due to fetal concerns) 4

Fourth-Line: Proton Pump Inhibitors

Omeprazole 20 mg is appropriate when:

  • Symptoms are intractable despite the above measures
  • Heartburn is severe enough to impact quality of life
  • The patient has complicated GERD 3, 4

Safety Evidence for Omeprazole in Pregnancy

FDA Classification and Human Data

The FDA label indicates that available epidemiologic data fail to demonstrate an increased risk of major congenital malformations or adverse pregnancy outcomes with first trimester omeprazole use 1. Multiple large studies support this:

  • Swedish Medical Birth Registry study: 955 infants exposed to omeprazole showed no increased rate of malformations, low birth weight, or low Apgar scores compared to the general population 1

  • Danish nationwide study: 1,800 live births with first trimester omeprazole exposure showed a 2.9% birth defect rate versus 2.6% in unexposed infants 1

  • European multicenter study: 295 pregnancies exposed to omeprazole (233 in first trimester) showed major anomaly rate of 3.6% versus 3.8% in controls—no significant difference 5

Third Trimester Specific Data

Multiple case series demonstrate safe use specifically in the third trimester:

  • Nine women treated with omeprazole during various pregnancy stages, including several throughout the third trimester, showed no adverse effects in mothers or newborns, with normal child development at 2-12 year follow-up 6
  • Case report of successful omeprazole use starting in third trimester with no adverse fetal effects 7

Important Caveats

Omeprazole is FDA Category C (versus Category B for other PPIs like lansoprazole and pantoprazole), meaning animal studies showed some adverse effects but human data are reassuring 3, 4. This classification is somewhat outdated given the extensive human safety data now available.

The third trimester carries less theoretical risk than first trimester exposure since organogenesis is complete. The main concerns from animal studies (embryo-lethality and bone morphology changes) occurred with doses 3.4-34 times higher than human doses and are not relevant to standard 20 mg dosing 1.

Practical Recommendation

For a woman in her third trimester with heartburn:

  1. If she has already tried lifestyle modifications and antacids without relief, omeprazole 20 mg daily is a reasonable and safe option 2, 1

  2. Start with once-daily dosing (typically in the morning), which is the standard studied dose 1

  3. Reassure the patient that extensive human data from multiple countries show no increased risk of birth defects or adverse pregnancy outcomes with omeprazole use 1, 5, 6

  4. Symptoms typically resolve after delivery, so this is time-limited therapy 2

The 2024 AGA guidelines on pregnancy-related GI disease emphasize that heartburn is common in the latter part of pregnancy and resolves after delivery, supporting a pragmatic approach to symptom management when conservative measures fail 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.